SEC Form 4 · accession 0001104659-15-067094
KYTHERA BIOPHARMACEUTICALS INC · KYTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John W Smither
Officer — Chief Financial Officer
Period of report
Sep 23, 2015
Accepted (ET)
Sep 24, 2015 · 9:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001436304
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 23, 2015 | M | 13,272 | $8.22 | A | 16,640 | D | |
| Common Stock | Sep 23, 2015 | S | 13,272 | $74.90 | D | 3,368 | D | |
| Common Stock | Sep 23, 2015 | M | 13,646 | $27.50 | A | 17,014 | D | |
| Common Stock | Sep 23, 2015 | S | 13,646 | $74.90 | D | 3,368 | D | |
| Common Stock | Sep 24, 2015 | M | 13,154 | $27.50 | A | 16,522 | D | |
| Common Stock | Sep 24, 2015 | S | 13,154 | $74.90 | D | 3,368 | D | |
| Common Stock | Sep 24, 2015 | M | 13,763 | $44.02 | A | 17,131 | D | |
| Common Stock | Sep 24, 2015 | S | 13,763 | $74.90 | D | 3,368 | D | |
| Common StockF3 | holding | — | — | — | 6,216 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $8.22 | Sep 23, 2015 | M | 13,272 | D | — | Feb 1, 2022 | Common Stock | 13,272 | 0 | D |
| Stock OptionsF2 | $27.50 | Sep 23, 2015 | M | 13,400 | D | — | Jan 29, 2023 | Common Stock | 13,400 | 6,700 | D |
| Stock OptionsF1 | $27.50 | Sep 23, 2015 | M | 246 | D | — | Jan 29, 2023 | Common Stock | 246 | 13,154 | D |
| Stock OptionsF1 | $27.50 | Sep 24, 2015 | M | 13,154 | D | — | Jan 29, 2023 | Common Stock | 13,154 | 0 | D |
| Stock OptionsF2 | $44.02 | Sep 24, 2015 | M | 13,763 | D | — | Jan 22, 2024 | Common Stock | 13,763 | 19,266 | D |
Explanation of responses
- F1The shares subject to these options vested 100% upon the achievement of certain performance milestones approved by the Issuer's Board of Directors.
- F225% of the shares subject to the option vested on the first anniversary measured from January 1, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- F3Shares held by the 1994 Smither Family Trust dated March 1, 1994 as amended March 23, 2006, John W. Smither and Noretha V. Smither, Trustees (the "1994 Smither Family Trust").